Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04903431 · ClinicalTrials.gov registry record · NA

Assessing the Effectiveness of Self- and Clinician-administered Crisis Response Planning for Suicide Risk

A NA study of Suicidal Ideation and Suicide, Attempted, sponsored by Ohio State University.

Completed
Registry status
NA
Development phase
75
Enrollment target
1
Study location

NCT04903431: Completed NA study of Suicidal Ideation and Suicide, Attempted, sponsored by Ohio State University.

NCT04903431 is a NA study of Suicidal Ideation and Suicide, Attempted that has completed, run by Ohio State University. The registered enrollment target is 75 participants, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04903431, a NA study of Suicidal Ideation and Suicide, Attempted, has completed, sponsored by Ohio State University.

COMPLETED
Registry status
NA
Development phase
75 participants
Enrollment target
1
Study location

Study Summary

The aim of the current project is to compare the use and preliminary effectiveness of a self-administered version of the Crisis Response Plan (CRP) in decreasing suicidal/death ideation and distress and increasing positive affect when compared to a clinician-administered version of the protocol in a sample of 150 military Veterans experiencing current death or suicidal ideation.

Primary Outcome

The Suicide Visual Analog Scale The S-VAS assesses "urge to kill myself" using a horizontal line with anchors on the left reflecting "none" (score: 0) and on the right reflecting "extreme" (score: 100). The S-VAS is initially presented with the indicator on the "none" position, and non-movement of the indicator is followed by a prompt to remind the participant to move the indicator, if relevant, to ensure response accuracy. Higher scores are indicative of greater severity

Interventions

  • BEHAVIORAL Crisis Response Planning for Suicide Risk

Study Locations (1)

Ohio

  • The Ohio State University - Columbus

Trial Details

FieldValue
Enrollment Target 75 participants
Start Date 2021-12-15
Est. Completion 2023-02-21
Phase NA
Ohio State University

552 total trials

What the finished NCT04903431 record still lists

NCT04903431 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 267-participant average among 84 other Suicidal Ideation trials with a reported enrollment target (72% lower).

The record links to 2 conditions, with Suicidal Ideation appearing as the primary indexed condition, and to 1 intervention - of which Crisis Response Planning for Suicide Risk is the first listed.

NCT04903431 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04903431 about?

NCT04903431 is a clinical study titled "Assessing the Effectiveness of Self- and Clinician-administered Crisis Response Planning for Suicide Risk". The aim of the current project is to compare the use and preliminary effectiveness of a self-administered version of the Crisis Response Plan (CRP) in decreasing suicidal/death ideation and distress and increasing positive affect when compared to a clinician-administered version of the protocol in a...

What is the current status of trial NCT04903431?

This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2021-12-15. Estimated completion is 2023-02-21.

What conditions does trial NCT04903431 study?

This clinical trial studies the following conditions: Suicidal Ideation, Suicide, Attempted.

What interventions are being tested in trial NCT04903431?

The interventions under investigation include: Crisis Response Planning for Suicide Risk (BEHAVIORAL).

Who is sponsoring clinical trial NCT04903431?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04903431 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Suicidal Ideation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04903431's enrollment target sits among peer trials

75 54th of 84 higher than 30 of 84 other Suicidal Ideation trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Suicidal Ideation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01535430 · 75 participants

    Assessment of Eloquent Function in Brain Tumor Patients

  • NCT01542879 · 75 participants · Phase 1

    Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer

  • NCT02232191 · 75 participants · Phase 2

    Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients

  • NCT02754544 · 75 participants · NA

    Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04903431, the US trial registry maintained by the National Library of Medicine. NCT04903431 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.